Search Results - "Safadi, Marco Aurélio"

Refine Results
  1. 1

    Vaccines and routine immunization strategies during the COVID-19 pandemic by Dinleyici, Ener Cagri, Borrow, Ray, Safadi, Marco Aurélio Palazzi, van Damme, Pierre, Munoz, Flor M.

    Published in Human vaccines & immunotherapeutics (01-02-2021)
    “…Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Varicella vaccination - the global experience by Wutzler, Peter, Bonanni, Paolo, Burgess, Margaret, Gershon, Anne, Sáfadi, Marco Aurélio, Casabona, Giacomo

    Published in Expert review of vaccines (03-08-2017)
    “…Varicella, although a frequently benign childhood disease, nevertheless represents a considerable health burden. WHO recommends including varicella vaccines in…”
    Get full text
    Journal Article
  5. 5

    Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil by Vespa, Glaucia, Constenla, Dagna O, Pepe, Camila, Safadi, Marco Aurélio, Berezin, Eitan, de Moraes, José Cássio, de Campos, Carlos Alberto Herrerias, Araujo, Denizar Vianna, de Andrade, Ana Lucia S S

    Published in Revista panamericana de salud pública (01-12-2009)
    “…To compare the costs and benefits of pneumococcal conjugate vaccination compared with no vaccination from the perspectives of the health care system and…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease by Souza, Alessandra R, Maruyama, Claudia M, Sáfadi, Marco Aurélio P, Lopes, Marta H, Azevedo, Raymundo S, Findlow, Helen, Bai, Xilian, Borrow, Ray, Weckx, Lily Y

    Published in Vaccine (05-08-2016)
    “…Abstract Background A decline of protective antibody titers after MCC vaccine has been demonstrated in healthy children, this may be an issue of concern for…”
    Get full text
    Journal Article
  13. 13

    A critical analysis of serogroup B meningococcal disease burden in Brazil (2001-2015): implications for public health decisions by Chicuto, Luciana Andrea Digieri, de Moraes, Camile, Cássio de Moraes, José, Sáfadi, Marco Aurélio P.

    Published in Human vaccines & immunotherapeutics (02-08-2020)
    “…The recent licensure of two different serogroup B recombinant protein meningococcal vaccines in Brazil emphasizes the importance of a better knowledge of the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Influence of the antiretroviral therapy on the growth pattern of children and adolescents living with HIV/AIDS by Almeida, Flávia Jacqueline, Kochi, Cristiane, Sáfadi, Marco Aurélio Palazzi

    Published in Jornal de pediatria (01-03-2019)
    “…Weight and height growth impairment is one of the most frequent manifestations in HIV-infected children and may be the first sign of disease, being considered…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention by Sáfadi, Marco Aurélio Palazzi, Cintra, Otávio Augusto Leite

    Published in Neurological research (New York) (01-04-2010)
    “…Objective: Meningococcal disease continues to be a serious public health concern, being associated with high morbidity and mortality rates in many countries…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review by Abitbol, Véronique, Sohn, Woo-Yun, Horn, Michael, Safadi, Marco Aurelio P.

    Published in Human vaccines & immunotherapeutics (01-08-2023)
    “…The four-component meningococcal serogroup B vaccine (4CMenB) is indicated for the prevention of invasive meningococcal disease (IMD) caused by Neisseria…”
    Get full text
    Journal Article
  20. 20

    Future challenges in the elimination of bacterial meningitis by Bottomley, Matthew J, Serruto, Davide, Sáfadi, Marco Aurélio Palazzi, Klugman, Keith P

    Published in Vaccine (30-05-2012)
    “…Highlights ► Bacterial meningitis has declined upon use of Hib, PCV and meningococcal conjugate vaccines. ► Group B streptococcus accounts for most neonatal…”
    Get full text
    Journal Article